| SydPath Information Sheet | Division of Clinical Pharmacology |
||
| ED Paracetamol Study | |||
| Introduction Paracetamol toxicity may occur due to deliberate over-ingestion with intent of self-harm or accidental overdose due to exceeding safe intake when self-medicating. The aim of this study is to identify patients in this second group where usual history-taking has not identified the paracetamol overdose. For information on acute paracetamol overdose see Paracetamol. Study Protocol All samples sent to pathology from the ED with a serum ALT >50 U/L will have a serum paracetamol assay performed on the sample unless the test has been performed previously. The results will be placed in Mediweb along with the other patient results. The therapeutic interval for serum paracetamol is 10 - 20 mg/L. As the time of maximum ingestion may be longer ago than the standard dosing interval, even a "therapeutic" concentration may reflect potentially dangerous ingestion and the usual paracetamol toxicity nomogram may not apply. All results >10 mg/L should be further investigated. In response to a serum paracetamol greater than 10 ug/L the following actions should be undertaken rapidly.
Medications containing paracetamol Below is an incomplete list of medications available in Australia containing paracetamol. For a complete list see MIMs.
|
|||
| Further information available for SydPath clients from Dr Graham Jones: 8382-9160 | |||
The
Pathology Service of St Vincent's Hospital, Sydney |
![]() |
| Last updated 6/12/04 | |